Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Diabetes Type 2: full-pipeline trial registry
12 of 25 indexed Diabetes Type 2 trials are currently recruiting.
Corpus placement: #652 of 28,707 conditions by registered trial count.
25 US clinical trials · 12 currently recruiting · #652 of 28,707 conditions by registered trial count
Diabetes Type 2: 25 US clinical trials tracked, 12 recruiting.
Diabetes Type 2 is the subject of 25 registered US clinical trials on ClinicalTrials.gov, 12 of them currently open to new participants. 4 are in Phase 3-4 (later-stage) and 4 in Phase 1-2 (earlier-stage). The most active sponsor is Scripps Whittier Diabetes Institute, running 2 of these trials.
Enrollment posture brief
Registry condition diabetes-type-2
OPEN 12 | RECR 48% | LATE 4 | EARLY 4 | RANK #652 | SPON 2
Volume-matched condition peers
Nearest open-share peer: GBM (48% recruiting · 25 trials)
Diabetes Type 2 lists 12 open slots (48% of 25 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Diabetes Type 2 on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Diabetes Type 2 is recruiting above its size-band peers.
12 of 25 indexed trials (48%) are open to enrollment, against a 39.7% average across 762 conditions with 20-99 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
Sponsorship of Diabetes Type 2 trials is spread across many organizations.
Scripps Whittier Diabetes Institute accounts for 2 of 25 trials (8%). 21 distinct sponsors appear on at least one study for this condition label.
-
Typical Diabetes Type 2 enrolment sits around 150 participants.
Median target enrolment is 150 among the 25 trials that report a genuine target (sentinel values excluded). 7 of those (28%) plan for fewer than 100 participants.
-
Diabetes Type 2 research is mostly interventional.
22 interventional and 3 observational studies make up this index (88% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
25 total, page 1 of 1
Triage Survey for Cardiovascular, Obesity, and Related Endocrine Trial Eligibility
Brooklyn Clinical Research
NCT06412536
Pharmacogenetics of Response to GLP1R Agonists
University of Maryland, Baltimore
NCT05071898
Enhancing Diabetes Management Approaches for Patients With Uncontrolled Diabetes
University of Wisconsin, Madison
NCT05912647
RESET System Pivotal Trial (Rev F)
Morphic Medical
NCT04101669
Dulce Digital 2.0 - Innovative Diabetes Self-Management in the Digital Age
Scripps Whittier Diabetes Institute
NCT05416060
Enhancing Digitally Delivered Diabetes Education With Real-Time CGM
Scripps Whittier Diabetes Institute
NCT06296550
Healthy Living Anson Study
University of North Carolina, Chapel Hill
NCT07126587
FELLAShip to Better Health
University of Alabama at Birmingham
NCT07220213
Harnessing Macrophage Lysosomal Lipid Metabolism in Obesity
Bettina Mittendorfer
NCT06335771
Pilot of Continuous Glucose Monitor-Augmented Food Is Medicine
University of North Carolina, Chapel Hill
NCT07148713
Time-Restricted Eating for Type II Diabetes: TRE-T2D
University of California, San Diego
NCT05365529
Medically Intensive Nutrition Therapy Program for Obesity and Diabetes in a Low-income Population
Massachusetts General Hospital
NCT05799222
Developing a Learning COmmunity to Increase eNgagemeNt and Enrollment in Cardiovascular Clinical Trials (CONNECT)
Johns Hopkins University
NCT06347484
Biological Sample Repository for Gastrointestinal Disorders
Pichamol Jirapinyo, MD, MPH
NCT05874726
Impact of a Community Health Worker Strategy on Produce Prescription Program Uptake Among People With Diabetes
Yale University
NCT06401668
Effect of Retatrutide Compared With Placebo in Adult Participants With Type 2 Diabetes and Inadequate Glycemic Control With Diet and Exercise Alone (TRANSCEND-T2D-1)
Eli Lilly and Company
NCT06354660
A Research Study to See How Switching From a Daily Basal Insulin to a New Weekly Insulin, Insulin Icodec, Helps in Reducing the Blood Sugar Compared to Daily Insulin Glargine in Adults With Type 2 Diabetes
Novo Nordisk A/S
NCT06340854
Reducing Distress and Improving Self-Care in Diabetes
University of California, San Francisco
NCT00714441
Comparison Study of the Glycemic Effects, Safety, and Tolerability of Exenatide Once Weekly Suspension to Sitagliptin and Placebo in Subjects With Type 2 Diabetes Mellitus
AstraZeneca
NCT01652729
Study Of Safety And Efficacy Of PF-04991532 In Subjects With Type 2 Diabetes Mellitus
Pfizer
NCT01336738
Phase II Safety and Efficacy Study of Oral ORMD-0801 in Patients With Type 2 Diabetes Mellitus
Oramed
NCT02496000
Lifestyle Interventions for Expectant Mothers (LIFE-Moms Phoenix) - Phoenix
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
NCT01812694
Dietary Approaches to Stop Hypertension for Diabetes
Johns Hopkins University
NCT04286555
Famine From Feast: Linking Vitamin C, Red Blood Cell Fragility, and Diabetes
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
NCT02107976
Cryovagotomy Diabetes Trial
Emory University
NCT04276051
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 2 |
| Phase 2 | 2 |
| Phase 3 | 4 |
Top Sponsors
Named interventions
Most-linked intervention names on Diabetes Type 2 records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Diabetes Type 2 trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Diabetes Type 2 page
25 registered trials, 12 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 12 Diabetes Type 2 trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Scripps Whittier Diabetes Institute sponsors the most Diabetes Type 2 trials on record, review their full trial history before evaluating a specific study. See Scripps Whittier Diabetes Institute's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Diabetes Type 2 condition card totals 25 registered trials; most-linked intervention Placebo; top US site state California. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.